 |
|
Identification of neoantigens derived from alternative splicing and RNA modification
Jiyeon Park, Yeun-Jun Chung
Genomics Inform. 2019;17(3):e23 Published online 2019 Aug 22 DOI: https://doi.org/10.5808/GI.2019.17.3.e23
|
|
Citations to this article as recorded by
 Generation of tumor neoantigens by RNA splicing perturbation
Adi Rosenberg-Mogilevsky, Zahava Siegfried, Rotem Karni
Trends in Cancer.2025; 11(1): 12. CrossRef Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
Toshiaki Takahashi, Kunitoshi Shigeyasu, Yoshitaka Kondo, Sho Takeda, Hibiki Umeda, Kazuya Moriwake, Masashi Kayano, Yuya Sakurai, Shunsuke Nakamura, Masafumi Takahashi, Kaori Nitta, Kazuhiro Yoshida, Yuki Matsumi, Hiroyuki Michiue, Hideki Yamamoto, Hiroy
BMC Cancer.2025;[Epub] CrossRef Mechanisms of immune tolerance breakdown in paraneoplastic neurological syndromes
E. Peter, P. Dumez, J. Honnorat, V. Desestret
Revue Neurologique.2024; 180(9): 931. CrossRef Molecular mimicry as a mechanism of viral immune evasion and autoimmunity
Cole Maguire, Chumeng Wang, Akshara Ramasamy, Cara Fonken, Brinkley Morse, Nathan Lopez, Dennis Wylie, Esther Melamed
Nature Communications.2024;[Epub] CrossRef Neoepitopes prediction strategies: an integration of cancer genomics and immunoinformatics approaches
Sandeep Kumar Dhanda, Swapnil Mahajan, Malini Manoharan
Briefings in Functional Genomics.2023; 22(1): 1. CrossRef Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy
Yu Cai, Rui Chen, Shenghan Gao, Wenqing Li, Yuru Liu, Guodong Su, Mingming Song, Mengju Jiang, Chao Jiang, Xi Zhang
Frontiers in Oncology.2023;[Epub] CrossRef Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, Zhao Huang, Canhua Huang, Li Fu
Signal Transduction and Targeted Therapy.2023;[Epub] CrossRef Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
Valentina Urzì Brancati, Letteria Minutoli, Herbert Ryan Marini, Domenico Puzzolo, Alessandro Allegra
Current Oncology.2023; 30(5): 4603. CrossRef Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, Sebastian Lange, Philipp Seifert, Clara von Frankenberg, Johannes Untch, Gabriela Zuleger, Mathias Wilhelm, Daniel P. Zolg, Florian S. Dreyer, Eva Bräunlein, Thomas Engleitner, Sebastian Uhrig, M
Nature Communications.2023;[Epub] CrossRef Computational immunogenomic approaches to predict response to cancer immunotherapies
Venkateswar Addala, Felicity Newell, John V. Pearson, Alec Redwood, Bruce W. Robinson, Jenette Creaney, Nicola Waddell
Nature Reviews Clinical Oncology.2023;[Epub] CrossRef Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy
Ravi K. Shah, Erin Cygan, Tanya Kozlik, Alfredo Colina, Anthony E. Zamora
Frontiers in Immunology.2023;[Epub] CrossRef Shedding light on the hidden human proteome expands immunopeptidome in cancer
Yongsheng Li, Yunpeng Zhang, Tao Pan, Ping Zhou, Weiwei Zhou, Yueying Gao, Shaojiang Zheng, Juan Xu
Briefings in Bioinformatics.2022;[Epub] CrossRef Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
Hongge Liang, Yan Xu, Minjiang Chen, Jing Zhao, Wei Zhong, Xiaoyan Liu, Xiaoxing Gao, Shanqing Li, Ji Li, Chao Guo, He Jia, Mengzhao Wang
Frontiers in Immunology.2022;[Epub] CrossRef Neoantigens – the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders
Muhammed B. Sabdia, Ann-Marie Patch, Hennes Tsang, Maher K. Gandhi
Blood Reviews.2022; 56: 100969. CrossRef Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
Ananya Hariharan, Weihong Qi, Hubert Rehrauer, Licun Wu, Manuel Ronner, Martin Wipplinger, Jelena Kresoja‐Rakic, Suna Sun, Lucia Oton‐Gonzalez, Marika Sculco, Véronique Serre‐Beinier, Clément Meiller, Christophe Blanquart, Jean‐François Fonteneau, Bart Vr
Molecular Oncology.2022; 16(22): 3949. CrossRef AS-CMC: a pan-cancer database of alternative splicing for molecular classification of cancer
Jiyeon Park, Jin-Ok Lee, Minho Lee, Yeun-Jun Chung
Scientific Reports.2022;[Epub] CrossRef Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma
Ivan Pourmir, Johanna Noel, Audrey Simonaggio, Stéphane Oudard, Yann-Alexandre Vano
World Journal of Urology.2021; 39(5): 1377. CrossRef Implications of Antigen Selection on T Cell-Based Immunotherapy
Faye Camp, Jill Slansky
Pharmaceuticals.2021; 14(10): 993. CrossRef Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity
Hai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis A. Chiriboga, Briana Zeck, Miguel Lopez De Rodas Gregorio, Catríona M. Dowling, Kristen Labbe, Jiehui Deng, Ting Chen, Hua Zhang, Paul Zappile, Ze Chen, Beatrix Ueberheide, A
Cancer Immunology Research.2021; 9(11): 1298. CrossRef Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
Dirk Brehmer, Lijs Beke, Tongfei Wu, Hillary J. Millar, Christopher Moy, Weimei Sun, Geert Mannens, Vineet Pande, An Boeckx, Erika van Heerde, Thomas Nys, Emmanuel M. Gustin, Bie Verbist, Longen Zhou, Yue Fan, Vipul Bhargava, Pegah Safabakhsh, Petra Vinke
Molecular Cancer Therapeutics.2021; 20(12): 2317. CrossRef Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Antonietta Rosella Farina, Lucia Cappabianca, Michela Sebastiano, Veronica Zelli, Stefano Guadagni, Andrew Reay Mackay
Journal of Experimental & Clinical Cancer Research.2020;[Epub] CrossRef Main Strategies for the Identification of Neoantigens
Alexander V. Gopanenko, Ekaterina N. Kosobokova, Vyacheslav S. Kosorukov
Cancers.2020; 12(10): 2879. CrossRef
|